Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tipack Ayothyapattanam Shanmugam
Institutions:
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
University of Tübingen
Observed institutions:
University of Würzburg,
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
University of Tübingen
ORCID:
0009-0006-9716-1725
Observed ORCID:
0009-0006-9716-1725
OpenAlex ID:
A5061273595
In Silico Studies Reveal Peramivir and Zanamivir as an Optimal Drug Treatment Even If H7N9 Avian Type Influenza Virus Acquires Further Resistance
2022
·
Edita Sarukhanyan
, Tipack Ayothyapattanam Shanmugam
, et al.
·
Molecules
·
16
PDF
Immune Architecture of Early Human Aortic Atherosclerosis Reveals Prominent T-Cell and Myeloid Compartments
2026
·
Tipack Ayothyapattanam Shanmugam
, Annemarie Witz
, et al.
·
JACC Basic to Translational Science
PDF
Atherosclerotic plaque-derived microparticles as exporters of thrombotic risk
2026
·
Tipack Ayothyapattanam Shanmugam
·
Nature Reviews Cardiology
Abstract Wed056: Trained Immunity Amplifies Interleukin-6 and Tumor Necrosis Factor-α Hyperresponsiveness in Human Monocytes Across Cardiometabolic Stimuli: A Systematic Review and Meta-analysis
2026
·
Tipack Ayothyapattanam Shanmugam
, Mir Wajid Majeed
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
Show more works
View as search
Works count:
4
Citation count:
16
H-index:
1
I10-index:
1
Year
Topic
Type